Streetbeat News

ASAPF

Aurora Spine Corp

Industry

Surgical and Medical Instrument Manufacturing

Open

0.25

Mkt cap

19M

Volume

6.7K

High

0.25

P/E Ratio

-25.00

52-wk high

0.34

Low

0.25

Div yield

N/A

52-wk low

0.16

Aurora Spine Corporation has obtained FDA 510(k) clearance for its AERO™ Facet Fusion System, a minimally invasive spinal surgery solution designed for patients with facet joint-related pain or instability. The system can be used from spinal levels C2 to S1 and is expected to begin initial surgeries in late Q3 2025.

Portfolio Pulse from

March 25, 2025 | 11:30 am

Portfolio Pulse from

March 25, 2025 | 11:30 am

Aurora Spine Corporation will attend the 2025 American Academy of Orthopaedic Surgeons Annual Meeting, showcasing its innovative spinal surgery devices.

Portfolio Pulse from

March 11, 2025 | 11:30 am

Aurora Spine Corporation has completed patient enrollment in its REFINE study, a groundbreaking clinical trial evaluating the ZIP™ Interspinous Fixation device for lumbar interlaminar fusion. This marks a significant milestone in spinal care advancement.

Portfolio Pulse from

March 10, 2025 | 11:30 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.